Prominent Neuroscientist Fired by Columbia, HHMI

The specific reason for Thomas Jessell’s dismissal has not been disclosed.

Written byShawna Williams
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Columbia University libraryPUBLICDOMAINPICTURES, GEORGE HODANUpdate (March 13): STAT News reports that some current and former Columbia students and postdocs have signed a petition urging the university to be more transparent about Jessell's infractions, and to put in place stronger protections for graduate students and postdocs.

Columbia University removed neuroscientist Thomas Jessell from his posts yesterday (March 7), The New York Times reports. The university says in a statement that “[t]hese decisions follow an investigation that revealed serious violations of University policies and values governing the behavior of faculty members in an academic environment,” but did not specify the nature of the violations. The Howard Hughes Medical Institute (HHMI), which had employed Jessell as an investigator since 1985, has also terminated him, according to Science.

Jessell is known for his work on how neurons control movement, according to the Times. He co-directed Columbia’s Kavli Institute and its Mortimer B. Zuckerman Mind Brain Behavior Initiative (MBBI) and was a past winner of the Kavli Prize for Neuroscience. Science notes that one of ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • Shawna was an editor at The Scientist from 2017 through 2022. She holds a bachelor’s degree in biochemistry from Colorado College and a graduate certificate in science communication from the University of California, Santa Cruz. Previously, she worked as a freelance editor and writer, and in the communications offices of several academic research institutions. As news director, Shawna assigned and edited news, opinion, and in-depth feature articles for the website on all aspects of the life sciences. She is based in central Washington State, and is a member of the Northwest Science Writers Association and the National Association of Science Writers.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies